NDRA · CIK 0001681682 · operating
ENDRA Life Sciences Inc. (NDRA) is a electromedical & electrotherapeutic apparatus company incorporated in DE, listed on the Nasdaq. With a market capitalization of $4 million, ENDRA Life Sciences Inc. is a micro-cap company. The stock currently trades at $3.83, down 7.80% today, with a 52-week range of $2.90–$11.96. The company trades at a trailing P/E of 0.2x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-56.94 | — | — | |
| 2023 | — | — | — | |
| 2022 | — | $-4.56 | -1528.6% | |
| 2021 | — | $-0.28 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-31 | 0001654954-25-003612 | SEC ↗ |
| 2023-12-31 | 2024-03-28 | 0001654954-24-003873 | SEC ↗ |
| 2022-12-31 | 2023-03-16 | 0001654954-23-003044 | SEC ↗ |
| 2021-12-31 | 2022-03-30 | 0001654954-22-004172 | SEC ↗ |
| 2020-12-31 | 2021-03-25 | 0001654954-21-003302 | SEC ↗ |
| 2019-12-31 | 2020-03-26 | 0001654954-20-003346 | SEC ↗ |
| 2018-12-31 | 2019-03-11 | 0001654954-19-002560 | SEC ↗ |
| 2017-12-31 | 2018-03-20 | 0001654954-18-002829 | SEC ↗ |